Searching... Searching...
  • NVP + NA
  • Köp NA
  • Sälj NA
  • Senast NA
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Financial Calendar

20 Nov

Interim Report January – September 2019

21 Aug

Interim Report January – June 2019

21 May

Interim Report January – March 2019

25 Apr

Annual General Meeting 2019

29 Mar

The 9th Annual Traumatic Brain Injury Conference

NeuroVive will participate at the 9th Annual Traumatic Brain Injury Conference in Washington, DC on 17 – 18 May 2019.

From the agenda, 17 May:

8:25 am Traumatic Brain Injury Biomarkers in Therapeutic Trials: Pharmacodynamic Perspectives
In this presentation, Dr. Wang and Dr. Hansson will discuss the following:
• Temporal profile of brain injury biomarkers following TBI
• Changes in biomarker levels in cerebrospinal fluid during NeuroSTAT (cyclosporine) treatment in severe TBI patients
• Utilization of TBI biomarkers in pharmaceutical development
Kevin K.W. Wang, Ph.D., Executive Director, Center for Neuroproteomics & Biomarkers Research, Chief – Translational Research, Associate Professor of Psychiatry, Neuroscience & Physiological Science, University of Florida, Department of Psychiatry, College of Medicine
Magnus Hansson, MD, Ph.D., Chief Medical Officer, VP Preclinical Development & Clinical Development, NeuroVive

28 Feb

Year-End Report 2018